Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.2M Buy
191,426
+10,268
+6% +$2.21M 0.24% 120
2026
Q1
$39.4M Sell
181,158
-1,257
-0.7% -$279K 0.21% 116
2025
Q4
$41.7M Sell
182,415
-5,545
-3% -$1.26M 0.22% 110
2025
Q3
$43.5M Sell
187,960
-3,329
-2% -$678K 0.23% 107
2025
Q2
$35.5M Buy
191,289
+4,968
+3% +$923K 0.19% 121
2025
Q1
$39M Buy
186,321
+13,308
+8% +$2.59M 0.23% 109
2024
Q4
$30.7M Buy
173,013
+1,759
+1% +$323K 0.17% 127
2024
Q3
$33.8M Sell
171,254
-579
-0.3% -$108K 0.19% 124
2024
Q2
$29.5M Buy
171,833
+549
+0.3% +$90.9K 0.18% 128
2024
Q1
$31.2M Sell
171,284
-13,798
-7% -$2.38M 0.19% 130
2023
Q4
$28.7M Buy
185,082
+2,794
+2% +$407K 0.19% 121
2023
Q3
$27.2M Sell
182,288
-7,851
-4% -$1.15M 0.21% 115
2023
Q2
$25.6M Sell
190,139
-2,804
-1% -$411K 0.19% 118
2023
Q1
$30.7M Sell
192,943
-8,701
-4% -$1.33M 0.24% 110
2022
Q4
$32.6M Buy
201,644
+3,752
+2% +$575K 0.27% 105
2022
Q3
$26.6M Buy
197,892
+469
+0.2% +$67.3K 0.23% 109
2022
Q2
$30.2M Sell
197,423
-4,703
-2% -$719K 0.25% 108
2022
Q1
$32.8M Buy
202,126
+2,844
+1% +$413K 0.22% 103
2021
Q4
$27M Buy
199,282
+21,588
+12% +$2.55M 0.18% 114
2021
Q3
$19.2M Buy
177,694
+42,478
+31% +$4.85M 0.14% 126
2021
Q2
$15.2M Buy
135,216
+22,528
+20% +$2.54M 0.12% 137
2021
Q1
$12.2M Buy
112,688
+9,109
+9% +$974K 0.11% 128
2020
Q4
$11.1M Buy
103,579
+1,651
+2% +$159K 0.11% 129
2020
Q3
$8.93M Sell
101,928
-3,116
-3% -$293K 0.1% 130
2020
Q2
$10.3M Buy
105,044
+11,942
+13% +$1.05M 0.13% 118
2020
Q1
$7.09M Buy
93,102
+14,614
+19% +$1.24M 0.1% 125
2019
Q4
$6.95M Sell
78,488
-616
-0.8% -$51.1K 0.07% 145
2019
Q3
$5.75M Buy
79,104
+188
+0.2% +$12.9K 0.07% 154
2019
Q2
$5.74M Sell
78,916
-1,968
-2% -$155K 0.07% 151
2019
Q1
$6.52M Sell
80,884
-8,600
-10% -$704K 0.08% 138
2018
Q4
$8.25M Sell
89,484
-3,686
-4% -$324K 0.11% 127
2018
Q3
$8.81M Sell
93,170
-8,451
-8% -$801K 0.1% 130
2018
Q2
$9.41M Buy
101,621
+1,787
+2% +$175K 0.12% 124
2018
Q1
$9.45M Sell
99,834
-33,403
-25% -$3.67M 0.12% 121
2017
Q4
$12.9M Sell
133,237
-2,392
-2% -$225K 0.15% 118
2017
Q3
$12.1M Sell
135,629
-6,008
-4% -$457K 0.15% 116
2017
Q2
$10.3M Buy
141,637
+29,502
+26% +$1.98M 0.14% 118
2017
Q1
$7.02M Sell
112,135
-877
-0.8% -$55.1K 0.1% 134
2016
Q4
$7.08M Sell
113,012
-8,541
-7% -$521K 0.1% 129
2016
Q3
$7.67M Buy
121,553
+17,780
+17% +$1.15M 0.11% 121
2016
Q2
$6.42M Buy
103,773
+7,433
+8% +$453K 0.1% 132
2016
Q1
$5.5M Sell
96,340
-1,282
-1% -$71.5K 0.09% 135
2015
Q4
$5.78M Buy
97,622
+19,458
+25% +$1.12M 0.09% 132
2015
Q3
$4.25M Buy
78,164
+2,572
+3% +$167K 0.07% 150
2015
Q2
$5.08M Sell
75,592
-1,517
-2% -$99K 0.08% 148
2015
Q1
$4.51M Buy
77,109
+6,851
+10% +$414K 0.07% 161
2014
Q4
$4.6M Sell
70,258
-19,998
-22% -$1.26M 0.07% 151
2014
Q3
$5.21M Sell
90,256
-3,891
-4% -$216K 0.09% 140
2014
Q2
$5.31M Buy
94,147
+705
+0.8% +$37K 0.09% 142
2014
Q1
$4.8M Sell
93,442
-1,992
-2% -$101K 0.09% 147
2013
Q4
$5.04M Sell
95,434
-1,192
-1% -$58.6K 0.09% 140
2013
Q3
$4.32M Sell
96,626
-3,615
-4% -$160K 0.09% 140
2013
Q2
$4.14M Buy
+100,241
New +$4.38M 0.09% 132

Other funds holding ABBV

Davenport & Co's ABBV Position: Q2 2026 in Review

Davenport & Co increased its AbbVie (ABBV) stake by 5.7% in Q2 2026, buying an estimated $2.21M and bringing the position to 191,426 shares worth $48.2M. The position accounts for 0.24% of the portfolio, ranked #120.

Davenport & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Davenport & Co held 191,426 shares of AbbVie worth $48.2M as of Q2 2026.
  • Davenport & Co bought 10,268 AbbVie shares in Q2 2026, an estimated $2.21M.
  • AbbVie made up 0.24% of Davenport & Co's portfolio in Q2 2026, its #120 holding.
  • Davenport & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.